Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults
BH Goldenson, AM Goodman… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Treatment of acute myeloid leukemia (AML) has changed dramatically in the
past ten years with the approval of targeted agents, the first of which was the anti-CD33 …
past ten years with the approval of targeted agents, the first of which was the anti-CD33 …
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults.
BH Goldenson, AM Goodman… - Expert Opinion on …, 2020 - europepmc.org
Treatment of acute myeloid leukemia (AML) has changed dramatically in the past ten years
with the approval of targeted agents, the first of which was the anti-CD33 antibody-drug …
with the approval of targeted agents, the first of which was the anti-CD33 antibody-drug …
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults
BH Goldenson, AM Goodman… - Expert opinion on …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Treatment of acute myeloid leukemia (AML) has changed dramatically in the
past ten years with the approval of targeted agents, the first of which was the anti-CD33 …
past ten years with the approval of targeted agents, the first of which was the anti-CD33 …